International Clinical Trial: The efficacy and safety of hierarchical collateral artery embolization (TAE) and sequential hepatic artery infusion chemotherapy (HAIC) in the treatment of unresectable primary hepatocellular carcinoma: a prospective real-world study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131652) titled 'The efficacy and safety of hierarchical collateral artery embolization (TAE) and sequential hepatic artery infusion chemotherapy (HAIC) in the treatment of unresectable primary hepatocellular carcinoma: a prospective real-world study' on Sept. 4.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Jiangjin Central Hospital of Chongqing

Condition: Initial unresectable primary hepatocellular carcinoma

Intervention: Convention TAE:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-10-10

Target Sample Size: Convention TAE:48;Multi-level collateral arte...